MetLife, Inc.
MET
$68.92
-$0.01-0.02%
Weiss Ratings | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Reward Grade | B- | |||
Rating Factors | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Good | |||
Growth Index | Fair | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.96 | |||
Price History | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 5.28% | |||
60-Day Total Return | 6.89% | |||
90-Day Total Return | 15.17% | |||
Year to Date Total Return | 9.35% | |||
1-Year Total Return | 20.28% | |||
2-Year Total Return | 3.55% | |||
3-Year Total Return | 18.33% | |||
5-Year Total Return | 70.91% | |||
52-Week High % Change | -7.01% | |||
52-Week Low % Change | 41.86% | |||
Price | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $74.68 | |||
52-Week Low Price | $48.95 | |||
52-Week Low Price (Date) | May 16, 2023 | |||
52-Week High Price (Date) | Apr 04, 2024 | |||
Valuation | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 50.71B | |||
Enterprise Value | 80.02B | |||
Price/Earnings (TTM) | 38.36 | |||
Earnings Per Share (TTM) | 1.83 | |||
Earnings Per Share Growth | -70.98% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.78 | |||
Price/Book (Q) | 1.71 | |||
Enterprise Value/Revenue (TTM) | 1.19 | |||
Price | $73.60 | |||
Enterprise Value/EBITDA (TTM) | 20.28 | |||
Enterprise Value/EBIT | 24.83 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 743.40M | |||
Dividend Yield | 2.97% | |||
Div. Per Share (Most Recent) | $0.52 | |||
Dividend Per Share (TTM) | $2.08 | |||
Payout Ratio (TTM) | 111.79% | |||
Dividend Per Share (Most Recent) | $0.52 | |||
Company Info | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 212 578 9500 | |||
Address | 200 Park Avenue New York, NY 10166-0188 | |||
Website | www.metlife.com | |||
Country | United States | |||
Year Founded | 1999 | |||
Profitability | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 4.78% | |||
Profit Margin | 2.35% | |||
Management Effectiveness | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 0.30% | |||
Return on Equity | 5.31% | |||
Income Statement | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 69.17B | |||
Total Revenue (TTM) | 66.90B | |||
Revenue Per Share | $89.99 | |||
Gross Profit (TTM) | 14.87B | |||
EBITDA (TTM) | 3.92B | |||
EBIT (TTM) | 3.20B | |||
Net Income (TTM) | 1.58B | |||
Net Income Avl. to Common (TTM) | 1.38B | |||
Total Revenue Growth (Q YOY) | 21.93% | |||
Earnings Growth (Q YOY) | -61.16% | |||
EPS Diluted (TTM) | 1.83 | |||
EPS Diluted Growth (Q YOY) | -60.73% | |||
Balance Sheet | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 30.36B | |||
Cash Per Share (Q) | $40.84 | |||
Total Current Assets (Q) | 72.05B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 30.25B | |||
Current Ratio (Q) | 1.542 | |||
Book Value Per Share (Q) | $41.07 | |||
Total Assets (Q) | 687.58B | |||
Total Current Liabilities (Q) | 46.73B | |||
Total Debt (Q) | 49.70B | |||
Total Liabilities (Q) | 657.33B | |||
Total Common Equity (Q) | 30.02B | |||
Cash Flow | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -10.25B | |||
Cash from Financing (TTM) | -2.94B | |||
Net Change in Cash (TTM) | 444.00M | |||
Levered Free Cash Flow (TTM) | -8.40B | |||
Cash from Operations (TTM) | 13.72B | |||